Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized,Double-Blind,Vehicle-controlled,Parallel,Phase II Study to Evaluate Efficacy and Safety of CSTC1 in Patient With Diabetic Foot Ulcers

NCT01813305 is registered in ClinicalTrials.gov with Charsire Biotechnology Corp. as lead sponsor.

NCT NCT01813305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01813305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized,Double-Blind,Vehicle-controlled,Parallel,Phase II Study to Evaluate Efficacy and Safety of CSTC1 in Patient With Diabetic Foot Ulcers
Lead sponsor
Charsire Biotechnology Corp.
Phase
Phase 2
Overall status
Completed
Start date
July 9, 2014
Completion date
January 7, 2020
Enrollment
124 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, diabetic foot ulcer, wounds